ClinicalTrials.gov
ClinicalTrials.gov Menu

Resource Availability Following Critical Illness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03800628
Recruitment Status : Recruiting
First Posted : January 11, 2019
Last Update Posted : January 14, 2019
Sponsor:
Collaborator:
Wake Forest University Health Sciences
Information provided by (Responsible Party):
Michelle McMoon, Walden University

Brief Summary:
The purpose of this qualitative study is to explore the vital issues in recovery of QOL from the perspective of survivors of critical illness and understand these patients' views on rehabilitative services in the United States (U.S.). The theoretical framework for this study is Max Weber's Rational Choice Theory (RCT). The research questions will focus on understanding post-ICU QOL and the patients' experience with rehabilitative services following critical illness. A phenomenological study design is being employed, using semi-structured individual interviews with critical illness survivors. Data from the interviews will be coded for thematic analysis. The implications for social change include defining the meaning of QOL for an ICU survivor and improving healthcare policies for the therapies necessary to return survivors to a life worth living.

Condition or disease Intervention/treatment
Quality of Life Other: qualitative study

Detailed Description:

The purpose of this qualitative study is to understand the patient perception of QOL after surviving critical illness and how survivors can help illuminate gaps in current health policies to provide better recovery resources for this growing population.

The central research questions are:

RQ1: What are the issues important to preserve quality of life from the perspective of critical illness survivors? RQ2: How do survivors of critical illness describe rehabilitative services after discharge?


Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Other
Time Perspective: Other
Official Title: Perception of Quality of Life and Resource Availability After Surviving Critical Illness
Actual Study Start Date : December 7, 2018
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : August 30, 2019

Intervention Details:
  • Other: qualitative study
    semi-structured interviews


Primary Outcome Measures :
  1. RQ1: What are the issues important to preserve quality of life from the perspective of critical illness survivors? [ Time Frame: 6 months ]
    semi-structured, open-ended qualitative interview



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
critical illness survivors
Criteria

Inclusion Criteria:

  • critical illness survivors within 18 months of ICU discharge
  • minimum 48 hours of mechanical ventilation
  • ability to read and understand English
  • over the age of 18

Exclusion Criteria:

  • emotional or psychological inability to participate in a 30-min interview
  • not meeting inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03800628


Contacts
Contact: Michelle M McMoon 410-300-2786 michelle.mcmoon@waldenu.edu

Locations
United States, North Carolina
Wake Forest Baptist Health Recruiting
Winston-Salem, North Carolina, United States, 27157
Contact: Rita Bakhru, MD       rbakhru@wakehealth.edu   
Contact: Mary LaRose, RN    336-716-4155    mlarose@wakehealth.edu   
Sponsors and Collaborators
Walden University
Wake Forest University Health Sciences

Responsible Party: Michelle McMoon, Principle Investigator, Walden University
ClinicalTrials.gov Identifier: NCT03800628     History of Changes
Other Study ID Numbers: 09-06-2018-0576535
First Posted: January 11, 2019    Key Record Dates
Last Update Posted: January 14, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Michelle McMoon, Walden University:
survivor
QOL
resources

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes